You can find the annual or quarterly income statement of Cabaletta Bio Inc here for insights into the performance and operational efficiency of Cabaletta Bio Inc.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

Operating expenses

14.32%52.02M

19.28%44.30M

26.12%42.61M

40.98%46.59M

50.29%45.51M

32.48%37.14M

45.96%33.78M

77.02%33.05M

90.55%30.28M

65.32%28.03M

41.98%23.15M

58.50%18.67M

21.67%15.89M

30.44%16.96M

17.34%16.30M

1.86%11.78M

17.18%13.06M

33.84%13.00M

48.91%13.89M

37.39%11.56M

36.05%11.14M

23.01%9.71M

59.22%9.33M

67.28%8.42M

115.47%8.19M

97.87%7.89M

183.78%5.86M

63.34%5.03M

--3.80M

--3.99M

--2.06M

--3.08M

R&D expenses

18.05%44.43M

28.72%37.35M

41.76%36.19M

51.48%39.82M

60.66%37.64M

32.18%29.02M

46.69%25.53M

90.69%26.29M

98.58%23.43M

76.55%21.95M

40.36%17.41M

67.81%13.79M

24.00%11.80M

35.61%12.44M

25.01%12.40M

0.58%8.22M

21.20%9.51M

39.87%9.17M

71.76%9.92M

44.58%8.17M

47.25%7.85M

41.90%6.56M

90.85%5.78M

75.47%5.65M

100.11%5.33M

67.33%4.62M

144.23%3.03M

24.37%3.22M

--2.66M

--2.76M

--1.24M

--2.59M

Depreciation, depletion, and amortization

-20.73%371.00K

-30.52%337.00K

-90.25%348.00K

-18.63%345.00K

9.86%468.00K

23.41%485.00K

962.50%3.57M

19.44%424.00K

15.14%426.00K

7.67%393.00K

-6.15%336.00K

-2.20%355.00K

55.46%370.00K

66.67%365.00K

52.99%358.00K

64.25%363.00K

46.91%238.00K

88.79%219.00K

112.73%234.00K

145.56%221.00K

107.69%162.00K

52.63%116.00K

115.69%110.00K

181.25%90.00K

271.43%78.00K

--76.00K

--51.00K

--32.00K

--21.00K

--0.00

----

Operating profit

-14.32%-52.02M

-19.28%-44.30M

-26.12%-42.61M

-40.98%-46.59M

-50.29%-45.51M

-32.48%-37.14M

-45.96%-33.78M

-77.02%-33.05M

-90.55%-30.28M

-65.32%-28.03M

-41.98%-23.15M

-58.50%-18.67M

-21.67%-15.89M

-30.44%-16.96M

-17.34%-16.30M

-1.86%-11.78M

-17.18%-13.06M

-33.84%-13.00M

-48.91%-13.89M

-37.39%-11.56M

-36.05%-11.14M

-23.01%-9.71M

-59.22%-9.33M

-67.28%-8.42M

-115.47%-8.19M

-97.87%-7.89M

-183.78%-5.86M

-63.34%-5.03M

---3.80M

---3.99M

---2.06M

---3.08M

Net non-operating interest income (expenses)

Non-operating interest income

13.76%1.60M

-27.64%1.08M

-31.90%1.33M

-25.20%1.81M

-47.33%1.41M

-50.17%1.49M

-13.85%1.95M

8.87%2.42M

90.81%2.68M

170.78%2.98M

270.49%2.26M

532.48%2.22M

835.33%1.40M

1979.25%1.10M

12100.00%610.00K

11600.00%351.00K

2400.00%150.00K

430.00%53.00K

-76.19%5.00K

-86.96%3.00K

-85.00%6.00K

-97.56%10.00K

-95.40%21.00K

-93.96%23.00K

-90.99%40.00K

-10.48%410.00K

185.63%457.00K

693.75%381.00K

--444.00K

--458.00K

--160.00K

--48.00K

Non-operating interest expense

-9.46%517.00K

116.33%636.00K

-25.80%555.00K

--584.00K

--571.00K

--294.00K

--748.00K

----

Special income (expenses)

----

--0.00

---400.00K

----

--0.00

100.00%0.00

----

--0.00

---6.24M

Other non-operating income (expenses)

-37.70%-84.00K

--341.00K

---79.00K

--498.00K

---61.00K

----

Income before tax

-13.05%-51.02M

-21.07%-43.52M

-28.64%-41.92M

-46.48%-44.87M

-63.50%-45.13M

-43.50%-35.94M

-56.02%-32.59M

-86.22%-30.63M

-90.53%-27.60M

-57.99%-25.05M

-33.10%-20.89M

-43.94%-16.45M

-12.22%-14.49M

-22.46%-15.85M

-12.99%-15.69M

1.15%-11.43M

-15.90%-12.91M

-33.44%-12.95M

-49.19%-13.89M

-37.73%-11.56M

-36.64%-11.14M

-29.62%-9.70M

-72.29%-9.31M

-80.49%-8.39M

-142.76%-8.15M

-111.92%-7.49M

-183.62%-5.40M

49.87%-4.65M

---3.36M

---3.53M

---1.91M

---9.28M

Income tax

--0.00

----

Income after tax

-13.05%-51.02M

-21.07%-43.52M

-28.64%-41.92M

-46.48%-44.87M

-63.50%-45.13M

-43.50%-35.94M

-56.02%-32.59M

-86.22%-30.63M

-90.53%-27.60M

-57.99%-25.05M

-33.10%-20.89M

-43.94%-16.45M

-12.22%-14.49M

-22.46%-15.85M

-12.99%-15.69M

1.15%-11.43M

-15.90%-12.91M

-33.44%-12.95M

-49.19%-13.89M

-37.73%-11.56M

-36.64%-11.14M

-29.62%-9.70M

-72.29%-9.31M

-80.49%-8.39M

-142.76%-8.15M

-111.92%-7.49M

-183.62%-5.40M

49.87%-4.65M

---3.36M

---3.53M

---1.91M

---9.28M

Net income from continuous operations

-13.05%-51.02M

-21.07%-43.52M

-28.64%-41.92M

-46.48%-44.87M

-63.50%-45.13M

-43.50%-35.94M

-56.02%-32.59M

-86.22%-30.63M

-90.53%-27.60M

-57.99%-25.05M

-33.10%-20.89M

-43.94%-16.45M

-12.22%-14.49M

-22.46%-15.85M

-12.99%-15.69M

1.15%-11.43M

-15.90%-12.91M

-33.44%-12.95M

-49.19%-13.89M

-37.73%-11.56M

-36.64%-11.14M

-29.62%-9.70M

-72.29%-9.31M

-80.49%-8.39M

-142.76%-8.15M

-111.92%-7.49M

-183.62%-5.40M

49.87%-4.65M

---3.36M

---3.53M

---1.91M

---9.28M

Net income attributable to controlling interests

-13.05%-51.02M

-21.07%-43.52M

-28.64%-41.92M

-46.48%-44.87M

-63.50%-45.13M

-43.50%-35.94M

-56.02%-32.59M

-86.22%-30.63M

-90.53%-27.60M

-57.99%-25.05M

-33.10%-20.89M

-43.94%-16.45M

-12.22%-14.49M

-22.46%-15.85M

-12.99%-15.69M

1.15%-11.43M

-15.90%-12.91M

-33.44%-12.95M

-49.19%-13.89M

-37.73%-11.56M

-36.64%-11.14M

-29.62%-9.70M

-72.29%-9.31M

-80.49%-8.39M

-142.76%-8.15M

15.50%-7.49M

-183.62%-5.40M

49.87%-4.65M

---3.36M

---8.86M

---1.91M

---9.28M

Preferred share dividend

----

-100.00%0.00

--0.00

--5.33M

----

--0.00

Net income attributable to common shareholders

-13.05%-51.02M

-21.07%-43.52M

-28.64%-41.92M

-46.48%-44.87M

-63.50%-45.13M

-43.50%-35.94M

-56.02%-32.59M

-86.22%-30.63M

-90.53%-27.60M

-57.99%-25.05M

-33.10%-20.89M

-43.94%-16.45M

-12.22%-14.49M

-22.46%-15.85M

-12.99%-15.69M

1.15%-11.43M

-15.90%-12.91M

-33.44%-12.95M

-49.19%-13.89M

-37.73%-11.56M

-36.64%-11.14M

-29.62%-9.70M

-72.29%-9.31M

-80.49%-8.39M

-142.76%-8.15M

15.50%-7.49M

-183.62%-5.40M

49.87%-4.65M

---3.36M

---8.86M

---1.91M

---9.28M

Basic earnings per share

53.72%-0.34

45.16%-0.39

36.00%-0.40

29.14%-0.44

-29.31%-0.73

-35.35%-0.71

-35.80%-0.63

-65.48%-0.62

-52.51%-0.56

-17.02%-0.52

10.25%-0.46

5.00%-0.37

16.96%-0.37

-0.03%-0.45

-5.30%-0.52

26.63%-0.39

1.11%-0.45

-9.50%-0.45

-37.76%-0.49

-48.76%-0.54

-27.20%-0.45

-23.73%-0.41

-87.48%-0.36

-75.03%-0.36

-137.82%-0.35

15.98%-0.33

-124.61%-0.19

49.87%-0.21

---0.15

---0.39

---0.08

---0.41

Diluted earnings per share

53.72%-0.34

45.16%-0.39

36.00%-0.40

29.14%-0.44

-29.31%-0.73

-35.35%-0.71

-35.80%-0.63

-65.48%-0.62

-52.51%-0.56

-17.02%-0.52

10.25%-0.46

5.00%-0.37

16.96%-0.37

-0.03%-0.45

-5.30%-0.52

26.63%-0.39

1.11%-0.45

-9.50%-0.45

-37.76%-0.49

-48.76%-0.54

-27.20%-0.45

-23.73%-0.41

-87.48%-0.36

-75.03%-0.36

-137.82%-0.35

15.98%-0.33

-124.61%-0.19

49.87%-0.21

---0.15

---0.39

---0.08

---0.41

Dividend per share

--0.00

Currency unit

--USD

Audit opinions

----

FAQs

How do I read Cabaletta Bio Inc's income statement on TradingKey?



Start with total revenue, then review cost of revenue, gross profit, operating expenses, operating profit, income before tax, net income, and EPS. Revenue shows the scale of the business, while margins and profit lines show whether that revenue is being converted into earnings efficiently.

What is the difference between quarterly and annual income statements?



A quarterly income statement shows performance for a three-month fiscal period, while an annual income statement summarizes the full fiscal year. Quarterly data is useful for tracking recent momentum and seasonality, while annual data is better for judging long-term growth, profitability, and business cycles.

What does YOY mean on the income statement page?



YOY means year over year. It compares a financial metric with the same period in the previous year, such as this quarter's revenue versus revenue in the same quarter last year. YOY comparison helps investors see growth trends while reducing the impact of normal seasonal changes.

Which income statement metrics matter most when analyzing CABA stock?



Important metrics include revenue growth, gross profit, gross margin, operating profit, operating margin, net income, EPS, R&D expenses, SG&A expenses, and tax expense. Investors usually look at these together to judge whether the company is growing, controlling costs, and improving profitability.

What was Cabaletta Bio Inc's net income for the year?



Cabaletta Bio Inc posted -167.86M in net income for fiscal year 2025.

How much net income did Cabaletta Bio Inc post in the last quarter?



Cabaletta Bio Inc reported -51.02M in net income for the latest quarter。

What was Cabaletta Bio Inc's annual operating profit?



Cabaletta Bio Inc's operating income was -172.24M for fiscal year 2025.

How is EPS related to the income statement?



EPS, or earnings per share, is based on net income divided by the number of shares outstanding. It helps investors understand how much profit the company generated for each share, but it should be reviewed alongside share count changes, margins, cash flow, and valuation metrics.